Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog
Tom Williams

Tom Williams

Life Sciences Professional Services Project Manager

Connect with Tom Williams on LinkedIn

About the author: Tom Williams, Ph.D., Life Sciences Professional Services, is a Life Sciences Project Manager, Knowledge Manager, and Research Scientist. He has extensive experience as an academic researcher in neurodegeneration and Alzheimer’s disease. He is also in skilled biophysical chemistry, dementia disorders, and biochemistry. He is the author of many publications in the field of Alzheimer’s disease. At Elsevier he delivers and implements information solutions for customers.

Posts by Tom Williams

New Study Offers Insight into Alzheimer’s Disease Research Landscape

Posted on September 9th, 2019 in Pharma R&D

The sixth leading cause of death in the U.S., and estimated to affect approximately 45 million people worldwide, Alzheimer’s is a progressive brain disease that causes memory loss and overall mental deterioration. Coinciding with World Alzheimer’s Month, Elsevier just released a report (which you can download here) analyzing Alzheimer’s research spanning the last 50 years in order to present a comprehensive overview of the research landscape for this irreversible condition.